Westfield Capital Management Co. LP Buys New Stake in DENTSPLY SIRONA Inc. (XRAY)

Westfield Capital Management Co. LP bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 448,855 shares of the medical instruments supplier’s stock, valued at approximately $26,846,000. Westfield Capital Management Co. LP owned 0.20% of DENTSPLY SIRONA at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Commonwealth Bank of Australia lifted its holdings in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares in the last quarter. Acrospire Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $113,000. Dupont Capital Management Corp purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $116,000. Massey Quick Simon & CO. LLC purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at about $124,000. Finally, Korea Investment CORP lifted its holdings in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after purchasing an additional 1,251 shares in the last quarter. Institutional investors own 96.58% of the company’s stock.

In related news, Director Francis J. Lunger sold 8,900 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Nicholas W. Alexos acquired 50,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average cost of $65.85 per share, for a total transaction of $3,292,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.99% of the company’s stock.

DENTSPLY SIRONA Inc. (XRAY) opened at $65.75 on Tuesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The stock has a market cap of $15,177.45, a P/E ratio of 26.33, a P/E/G ratio of 2.62 and a beta of 1.31. DENTSPLY SIRONA Inc. has a one year low of $52.53 and a one year high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 earnings per share. research analysts forecast that DENTSPLY SIRONA Inc. will post 2.66 EPS for the current fiscal year.

XRAY has been the topic of several recent research reports. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, October 30th. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 price target on shares of DENTSPLY SIRONA in a report on Monday, November 6th. Morgan Stanley reaffirmed an “overweight” rating and issued a $69.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 16th. Finally, TheStreet raised shares of DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $67.73.

COPYRIGHT VIOLATION WARNING: “Westfield Capital Management Co. LP Buys New Stake in DENTSPLY SIRONA Inc. (XRAY)” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2017/12/05/westfield-capital-management-co-lp-buys-new-stake-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply